Go to navigation Go to content
Toll-Free: 877-BRENT-ADAMS
Phone: (919) 781-7590
Brent Adams & Associates

Actos Drug Maker Agrees to Pay Billions to Bladder Cancer Plaintiffs

Blog Category:
Comments (0)

actos drug injuriesTakeda Pharmaceutical Company, a Japanese-based drug manufacturer of prescription medication Actos, was found to have cancer-causing properties in Actos. Actos is a medication designed to help regulate glucose levels in adults who have type 2 diabetes. The FDA issued a safety warning for the drug claiming Actos could increase your risk of bladder cancer. This drug was on the market for 12 years and more than 9,000 bladder cancer patients have come forward to receive compensation.

A three-year study by a French research company found the ingredient in Actos called pioglitazone causes an increased risk for bladder cancer. But not only can Actos increase one's risk to have bladder cancer, this drug is also linked to several other side effects:

  • Abnormal heart conditions
  • Swelling in ankles or legs
  • Shortness of breath
  • Rapid increase in weight
  • Blood in urine
  • Diabetic eye disease
  • Fractures


Takeda has agreed to pay $2.37 billion collectively to plaintiffs who claim Actos caused their bladder cancer. Some people claim the company hid these risks from doctors and consumers, however, despite these accusations, Takeda still stands by their product. Their agreement to settle is to prevent complex litigations in the future. 

Curious if other drugs might be causing health issues for you or a loved one? Read a list of drugs recalled in 2016.

Category: Defective Drugs

There are no comments.

Post a comment

Post a Comment to "Bladder Cancer Patients Linked to Actos Prescription"

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.